Cargando…

Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention

OBJECTIVE: To investigate the preventive effect of hydration combined with reduced glutathione on contrast-induced nephropathy (CIN) after coronary intervention therapy in elderly Chinese patients with diabetes. METHODS: Patients with diabetes aged ≥65 years, who received percutaneous coronary inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingqing, Xu, Enguo, Ren, Shijia, Gu, Xingjian, Zheng, Jiping, Yang, Jianguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705794/
https://www.ncbi.nlm.nih.gov/pubmed/33243032
http://dx.doi.org/10.1177/0300060520964017
_version_ 1783617020369043456
author Wang, Lingqing
Xu, Enguo
Ren, Shijia
Gu, Xingjian
Zheng, Jiping
Yang, Jianguang
author_facet Wang, Lingqing
Xu, Enguo
Ren, Shijia
Gu, Xingjian
Zheng, Jiping
Yang, Jianguang
author_sort Wang, Lingqing
collection PubMed
description OBJECTIVE: To investigate the preventive effect of hydration combined with reduced glutathione on contrast-induced nephropathy (CIN) after coronary intervention therapy in elderly Chinese patients with diabetes. METHODS: Patients with diabetes aged ≥65 years, who received percutaneous coronary intervention (PCI) between 1 August 2016 and 31 December 2018, were enrolled and randomized into two groups: patients treated with hydration combined with reduced glutathione (treatment group) and patients who received hydration alone (controls). Serum creatinine and creatinine clearance levels were measured in all patients before PCI and then daily for 3 days after PCI. Occurrence of CIN (the primary endpoint) was defined as serum creatinine value 25% or 44.2 mmol/l (0.5 mg/dl) above baseline at 72 h after an exposure to contrast medium. RESULTS: A total of 396 patients were included (treatment group, n = 204; and controls, n = 192). The CIN occurrence rate in the treatment and control group was 5.88% and 6.77%, respectively, with no statistically significant between-group difference. CONCLUSION: In elderly patients with diabetes receiving PCI, the risk of CIN was not effectively lowered by hydration combined with reduced glutathione.
format Online
Article
Text
id pubmed-7705794
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77057942020-12-07 Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention Wang, Lingqing Xu, Enguo Ren, Shijia Gu, Xingjian Zheng, Jiping Yang, Jianguang J Int Med Res Prospective Clinical Research Report OBJECTIVE: To investigate the preventive effect of hydration combined with reduced glutathione on contrast-induced nephropathy (CIN) after coronary intervention therapy in elderly Chinese patients with diabetes. METHODS: Patients with diabetes aged ≥65 years, who received percutaneous coronary intervention (PCI) between 1 August 2016 and 31 December 2018, were enrolled and randomized into two groups: patients treated with hydration combined with reduced glutathione (treatment group) and patients who received hydration alone (controls). Serum creatinine and creatinine clearance levels were measured in all patients before PCI and then daily for 3 days after PCI. Occurrence of CIN (the primary endpoint) was defined as serum creatinine value 25% or 44.2 mmol/l (0.5 mg/dl) above baseline at 72 h after an exposure to contrast medium. RESULTS: A total of 396 patients were included (treatment group, n = 204; and controls, n = 192). The CIN occurrence rate in the treatment and control group was 5.88% and 6.77%, respectively, with no statistically significant between-group difference. CONCLUSION: In elderly patients with diabetes receiving PCI, the risk of CIN was not effectively lowered by hydration combined with reduced glutathione. SAGE Publications 2020-11-26 /pmc/articles/PMC7705794/ /pubmed/33243032 http://dx.doi.org/10.1177/0300060520964017 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Prospective Clinical Research Report
Wang, Lingqing
Xu, Enguo
Ren, Shijia
Gu, Xingjian
Zheng, Jiping
Yang, Jianguang
Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
title Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
title_full Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
title_fullStr Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
title_full_unstemmed Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
title_short Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
title_sort reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
topic Prospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705794/
https://www.ncbi.nlm.nih.gov/pubmed/33243032
http://dx.doi.org/10.1177/0300060520964017
work_keys_str_mv AT wanglingqing reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention
AT xuenguo reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention
AT renshijia reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention
AT guxingjian reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention
AT zhengjiping reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention
AT yangjianguang reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention